Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 2
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 24, 2023
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 2
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 25 Baiya SARS-CoV-2 Vax 2
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
3M Adjuvant Boosts Immune Response to Plant-Based COVID-19 Vaccine in Thailand Clinical Trials
Details : Baiya’s SARS-CoV-2 Vax 2 is second-generation plant-produced vaccine modelled on prototype SARS-CoV-2 RBD antigen adjuvanted with 3M-052-AF-alum. Data from first cohort of 12 participants demonstrated no significant changes in vital signs during first ...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 29, 2022
Lead Product(s) : 25 Baiya SARS-CoV-2 Vax 2
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 2
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : National Vaccine Institute, Thailand
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
January 19, 2022
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 2
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : National Vaccine Institute, Thailand
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 1
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : National Vaccine Institute, Thailand
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
July 07, 2021
Lead Product(s) : Baiya SARS-CoV-2 Vaccine 1
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : National Vaccine Institute, Thailand
Deal Size : Inapplicable
Deal Type : Inapplicable